3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 4
1
Status
Recruiting
2
Terminated
1
Active not recruiting
1
Sponsor Class
INDUSTRY
3
OTHER
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Myeloid
4
Conditions
Polycythemia Vera
4
Leukemia, Myeloid, Acute
4
Treatment-Refractory Solid Tumors
2
Meningioma
2
Squamous Cell Carcinoma of Head and Neck
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Chronic
1
Head and Neck Neoplasms
1
Bone Marrow Neoplasms
1
Bites and Stings
1
Interventions
ruxolitinib
10
fludarabine phosphate
5
Whole-Body Irradiation
5
Cyclophosphamide
5
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Hydroxyurea
4
bomedemstat
3
Stem Cell Transplantation
3
Specimen Handling
3
Busulfan
3
Biopsy
3
Aspirin
3
fludarabine
2
Phlebotomy
2
Methotrexate
2
Melphalan
2
Injections
2
Azacitidine
2
venetoclax
1
veliparib
1
umbralisib
1
piperine
1
pevonedistat
1
methanesulfonic acid
1
itacitinib
1
iadademstat
1
givinostat hydrochloride
1
givinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Polycythemia Vera
×
Hydroxyurea
×
1 year
×
Clear all
NCT05853458
2026-04-30
HU-F-AIM
Novartis
Phase 4
Terminated
76 enrolled
NCT04116502
2026-04-28
MITHRIDATE
University of Birmingham
Phase 3
Recruiting
586 enrolled
NCT06093672
2026-03-25
GIV-IN-PV
Italfarmaco
Phase 3
Recruiting
220 enrolled
NCT05548062
2025-09-03
Prospero
Novartis
Active not recruiting
242 enrolled